Feedback / Questions
CHM 1101 - Chimeric Therap
https://www.proactiveinvestors.com.au/companies/news/1001934/chimeric-therapeutics-completes-dosing-in-third-dose-cohort-of-chm-1101-phase-1-clinical-trial-1001934.html
Dec 22, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next